-
Hyderabad: The repeated cycle of Covid reinfections and associated illness among individuals who test positive due to the new variants of Omicron has now fuelled the demand for updating the existing Covid vaccines. While the present-day Covid vaccines including the precautionary or booster doses have accorded protection from severe hospitalisations and deaths, they however have […]
-
The global fears over the emergence of Omicron, the new and more virulent coronavirus variant, once again highlight an often neglected aspect of the pandemic: Vaccine inequality. The widening gulf between the rich and the poor nations in terms of inoculation coverage makes the fight against the virus less effective. Access to life-saving vaccines makes […]
-
Hyderabad: The Biden administration has announced revised international air travel rules for those flying to the United States, with the rules to come into effect from November 8. According to a communiqué from the White House, details of which are available on www.cdc.gov/ and https://travel.state.gov/content/travel.html as well, starting November 8, all foreign national air travellers […]
-
As against 86 lakh doses that need to be administered per day, the vaccination rate has been just 40 lakh a day over the past week
-
The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.
-
Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik
-
Even 15 weeks after the first dose, eight of 10 people still had detectable germinal centers containing B cells targeting the virus.
-
The study, published on Thursday in the journal JAMA, recruited 45 healthy male volunteers aged 18 to 50 years scheduled for mRNA COVID-19 vaccination by Pfizer-BioNTech and Moderna.
-
To evaluate SARS-CoV-2 infant vaccination, the researchers immunised two groups of 8 infant rhesus macaques at 2.2 months of age and 4 weeks later.
-
Scores of NRIs who had gone to India had taken Covishield as it continues to be the mainstay of India’s Covid-19 vaccination drive
-
The Centre should consider utilising its position as the monopolistic buyer in the market and pass down the benefit to all people
-
It is imperative to note that while every university has different rules, we expect many of them will require students to be vaccinated to participate in on-campus study
-
Passengers arriving in Saudi Arabia must submit a vaccination certificate showing they have received the approved shot, according to guidelines issued by the General Authority of Civil Aviation
-
Anticipating the shortages, many States including Telangana had recently gone for global tenders
-
The daily vaccination rate has fallen to 1.3 million doses despite India not exporting the vaccines now
-
Under the agreement, the biotech unit of Samsung Group will provide the U.S. drugmaker with contract manufacturing organization (CMO) services for its mRNA vaccine. It means that some of the Moderna vaccine would be produced in South Korea.
-
States like Telangana opting for global tenders to procure vaccine is a pragmatic decision, given the Centre's opaque policy
-
Nearly 51 per cent of Moderna recipients had full-body symptoms, compared with 48 per cent of people who got the Pfizer/BioNTech shot.
-
Results showed that following the second dose of vaccine, risk of infection was reduced by 90 per cent two or more weeks after vaccination, the CDC said on Monday.
-
Different types of COVID-19 vaccines have been authorised and it's possible side effects will differ for each.